After Ancheng Pharmaceutical launched an over-the-counter attack on new drug stocks.
After Ancheng Pharmaceutical launched an over-the-counter attack on new drug stocks.
Ancheng International Pharmaceutical Co., Ltd. was listed at 248 yuan per share yesterday, rising 42% to 351 yuan in intraday trading, after it became a new drug stock. Chairman Chen Zhiming said that efforts will be made to repay the support of investors.
An Chengyao is the first Taiwanese pharmaceutical company to focus on category IV (Paragraph IV) simplified new drug marketing procedures (ANDA) and high-tech generic drugs. It has submitted nine ANDA applications to the US Food and Drug Administration (FDA). Products for the treatment of attention deficit hyperactivity disorder have been provisionally approved by FDA (tentative approval).
Chen Zhiguang, general manager of Anchengyao, said it is estimated that two or three products will be sold in the US market next year. In addition to Paragraph IV and high-tech threshold generic drugs, it also actively develops a number of new drugs with market potential through its 100%-owned subsidiary Ancheng Biotech. Ongoing new drug development projects include two small molecular new drugs and one large molecular new drug.
Chen Zhiguang said that in addition to the layout of special scientific name drugs, an Chengyao has spared no effort in new drug development, and among the three new drugs invested, in addition to the AC-301 for the treatment of ocular angiogenesis diseases, the new diabetes drug AC-201 and the new rose spot treatment drug AC-701 have entered the second phase of FDA clinical trials in the United States.
As for the bright performance of the stock price on the first day of the OTC, Chen Zhiming said that he was very glad that the investors supported an Chengyao and would make efforts to repay the investors.
An proprietary medicine's revenue in the first three quarters of this year was 192 million yuan, an annual decrease of 30%, and an after-tax loss of nearly 320 million yuan, or 3.24 yuan per share. With the drugs coming on the market one after another, we will turn losses into profits next year.
- Prev
NB shipments grew better than expected in November
According to statistics, shipments of the world's top five brands NB (laptops) rose 14% in November, better than expected, mainly from a large number of orders from HP's education market in India, which once again reached 3 million units. DIGITIMESResearch statistics, November the world's top 5 brands and the top 3.
- Next
Chen Deming's visit to Hon Hai received by Terry Gou in person
An exchange delegation led by Chen Deming, chairman of the Association for Relations across the Taiwan Strait (ARATS), visited the Hon Hai Tucheng Dingpu plant yesterday morning, which was personally received by Hon Hai Chairman Terry Gou. Chen Deming, co-president of cross-strait relations on the mainland, led the economic and trade exchange delegation of the Association for Relations across the Taiwan Strait to Taiwan on November 26.
Related
- A course of planting techniques and methods on how to grow carrots
- How to plant the latest tulips?
- Is it better to pick tea in the morning or in the afternoon? When is the best time for tea to be picked? what is the third or fifth tea?
- Launch Yuanxiao Happy combination Haocha + Tea Yuan healthy Taste
- Penghu Tourism "Fireworks 20 Parade with You"
- 2022 West Lake Happiness holds "Digital Revitalization Voucher" and draws iphone13 and laptop.
- Banqiao Fuzhou social houses are designed to change start-up combined with police elimination to create a safe and livable environment
- The convenient measure of "mechanical weeding" in Xinbei has been abused and the Agriculture Bureau has imposed heavy penalties on the illegal land consolidation.
- Changgeng University Joins Hands with Four Memory Factories to Rescue Memory Talent Shortage
- The list of Taiwan's top 100 MVP managers is listed by the Director-General of the Farmers' Association of Sanxia District.